Literature DB >> 23153876

Hypovolemic shock resuscitation.

Leslie Kobayashi1, Todd W Costantini, Raul Coimbra.   

Abstract

Several changes in the way patients with hemorrhagic shock are resuscitated have occurred over the past decades, including permissive hypotension, minimal crystalloid resuscitation, earlier blood transfusion, and higher plasma and platelet-to-red cell ratios. Hemostatic adjuncts, such as tranexamic acid and prothrombin complex, and the use of new methods of assessing coagulopathy are also being incorporated into resuscitation of the bleeding patient. These ideas have been incorporated by many trauma centers into institutional massive transfusion protocols, and adoption of these protocols has resulted in improvements in mortality and morbidity. This article discusses each of these new resuscitation strategies and the evidence supporting their use.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23153876     DOI: 10.1016/j.suc.2012.08.006

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  9 in total

1.  Impact of early haemodynamic goal-directed therapy in patients undergoing emergency surgery: an open prospective, randomised trial.

Authors:  Gordana Pavlovic; John Diaper; Christoph Ellenberger; Angela Frei; Karim Bendjelid; Fanny Bonhomme; Marc Licker
Journal:  J Clin Monit Comput       Date:  2015-04-08       Impact factor: 2.502

Review 2.  Hypertonic Saline in the Treatment of Hemorrhagic Shock.

Authors:  Elnaz Vahidi; Zeinab Naderpour; Morteza Saeedi
Journal:  Adv J Emerg Med       Date:  2017-10-13

3.  Sodium bicarbonated Ringer's solution effectively improves coagulation function and lactic acid metabolism in patients with severe multiple injuries and traumatic shock.

Authors:  Jianzhong Ma; Shengjin Han; Xiaolin Liu; Zhengwu Zhou
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

4.  Time-Dependent Production of Endothelium-Related Biomarkers is Affected Differently in Hemorrhagic and Septic Shocks.

Authors:  Cenk Nuri Coskun; Suzan Emel Usanmaz; Vahide Savci; Emine Demirel-Yilmaz
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

5.  Resuscitative Effect of Centhaquine (Lyfaquin®) in Hypovolemic Shock Patients: A Randomized, Multicentric, Controlled Trial.

Authors:  Anil Gulati; Dinesh Jain; Nilesh Radheshyam Agrawal; Prashant Rahate; Rajat Choudhuri; Soumen Das; Deba Prasad Dhibar; Madhav Prabhu; Sameer Haveri; Rohit Agarwal; Manish S Lavhale
Journal:  Adv Ther       Date:  2021-05-10       Impact factor: 3.845

Review 6.  The effectiveness of prehospital hypertonic saline for hypotensive trauma patients: a systematic review and meta-analysis.

Authors:  I E Blanchard; A Ahmad; K L Tang; P E Ronksley; D Lorenzetti; G Lazarenko; E S Lang; C J Doig; H T Stelfox
Journal:  BMC Emerg Med       Date:  2017-11-28

7.  Involvement of median preoptic nucleus and medullary noradrenergic neurons in cardiovascular and sympathetic responses of hemorrhagic rats.

Authors:  Lara Marques Naves; Stefanne Madalena Marques; Aline Andrade Mourão; James Oluwagbamigbe Fajemiroye; Carlos Henrique Xavier; Carlos Henrique de Castro; Ana Cristina Silva Rebelo; Daniel Alves Rosa; Rodrigo Mello Gomes; Eduardo Colombari; Gustavo Rodrigues Pedrino
Journal:  Sci Rep       Date:  2018-07-26       Impact factor: 4.379

8.  Use of noninvasive volume assessment methods to predict acute blood loss in spontaneously breathing volunteers.

Authors:  Asim Tomo; Murat Pekdemir; Ibrahim Ulas Ozturan; Nurettin Ozgur Dogan; Elif Yaka; Serkan Yilmaz
Journal:  Clin Exp Emerg Med       Date:  2021-03-31

9.  A Multicentric, Randomized, Controlled Phase III Study of Centhaquine (Lyfaquin®) as a Resuscitative Agent in Hypovolemic Shock Patients.

Authors:  Anil Gulati; Rajat Choudhuri; Ajay Gupta; Saurabh Singh; S K Noushad Ali; Gursaran Kaur Sidhu; Parvez David Haque; Prashant Rahate; Aditya R Bothra; Gyan P Singh; Sanjiv Maheshwari; Deepak Jeswani; Sameer Haveri; Apurva Agarwal; Nilesh Radheshyam Agrawal
Journal:  Drugs       Date:  2021-06-01       Impact factor: 9.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.